Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Gastric Cancer：MetBio-GC
A clinical trial to develop and validate metabolic biomarkers for early diagnosis, prognosis, and recurrence of gastric cancer is currently …
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: A Study of Minimally Invasive Proximal Gastrectomy Versus Minimally Invasive Total Gastrectomy for Gastric and Gastroesophageal Junction Cancers
A clinical trial comparing minimally invasive proximal gastrectomy versus minimally invasive total gastrectomy for gastric and gastroesophag…
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: HER2-positive Locally Advanced/Metastatic Gastric and/or Gastroesophageal Junction (GEJ) Adenocarcinoma in Russia
AstraZeneca's clinical trial in Russia evaluating HER2-positive gastric and gastroesophageal junction adenocarcinoma has completed (NCT05892…
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Tislelizumab Plus FOLFOX Versus POF in the Treatment of Locally Advanced: a Multicenter, Open-label, Randomized Phase III Studyunresectable or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma [Phase 3]
A multicenter, open-label Phase III study randomizes tislelizumab plus FOLFOX versus POF in locally advanced or metastatic gastric and gastr…
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: Predicting the Efficacy in Advanced Gastric Cancer.
This update reports a completed clinical trial assessing predicted efficacy in advanced gastric cancer. The study involves paclitaxel and ra…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours [Phase 1, Phase 2]
NuCana plc announced termination of a Phase 1/2 trial evaluating NUC-3373 in combination with other agents for patients with advanced solid …
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: The Construction of a Predictive Model for Gastric Cancer Immunotherapy Response Based on Tumor-Infiltrating Lymphocytes (TILs) and Histone H3K4me3 in the Tumor Microenvironment
This clinical trial update describes a study to construct a predictive model for gastric cancer immunotherapy response based on tumor-infilt…
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: Gastrectomy + Cytoreductive Surgery + HIPEC for Gastric Cancer With Peritoneal Dissemination. [Phase 3]
A Phase 3 clinical trial evaluating gastrectomy with cytoreductive surgery and HIPEC for gastric cancer with peritoneal dissemination is cur…
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: Perioperative Tislelizumab Plus Chemotherapy Versus Chemotherapy Alone in MHC-II-Positive Gastric/GEJ Cancer [Phase 3]
A Phase 3 trial is investigating perioperative tislelizumab plus chemotherapy versus chemotherapy alone for MHC-II-positive gastric/GEJ canc…
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: Study of SBRT/Olaparib Followed by Pembrolizumab/Olaparib in Gastric Cancers [Phase 2]
A Phase 2 clinical trial evaluating SBRT/Olaparib followed by Pembrolizumab/Olaparib in gastric and gastroesophageal cancers; currently acti…
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: Clinical Evaluation of GRAPE Model for Gastric Cancer Screening
An ongoing clinical trial assessing the GRAPE model for gastric cancer screening, currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: Clinical Validation of an MCED Test in Symptomatic Populations (K-ACCELERATE)
This update describes the ongoing clinical validation of a multi-cancer early detection (MCED) test in symptomatic populations, with enrollm…
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: The Efficacy and Safety of HIPEC Combined With PD-1 and SOX Chemotherapy for the Translational Treatment of GC or EGJC With PM [Phase 2]
Phase 2 trial evaluating the efficacy and safety of HIPEC combined with a PD-1 inhibitor and S-1 plus oxaliplatin chemotherapy in metastatic…
-
CLINICAL_TRIALS trial_result · 2025-07-11Clinical Trial Update: INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors [Phase 1]
A Phase 1 trial of INCB106385, alone or with immunotherapy, in advanced solid tumors has completed. The study includes multiple indications …
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: T-Dxd in Combination With Ramucirumab as HER2 Low Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating trastuzumab deruxtecan in combination with ramucirumab for HER2-low gastric or gastroesophageal juncti…
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Predicting Peripheral Neuropathy of Paclitaxel for Gastric Cancer
A clinical trial is recruiting to develop a predictive model for paclitaxel-induced peripheral neuropathy in gastric cancer patients, involv…
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2 [Phase 1]
Phase 1 clinical trial evaluating XMT-2056 in HER2-expressing advanced or recurrent solid tumors; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Pembrolizumab, Olaparib, Recurrent/Advanced Gastric and Gastro-esophageal Junction(GEJ) Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the combination of pembrolizumab and olaparib for recurrent/advanced gastric cancer and gastroesophage…
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Pembrolizumab and Trifluridine/Tipiracil With Previously Treated Advanced Gastric Cancer [Phase 1, Phase 2]
This clinical trial evaluates the combination of pembrolizumab with trifluridine/tipiracil in patients with previously treated advanced gast…
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: Neoadjuvant Cadonilimab Combined With Perioperative Oxaliplatin Plus S1 for Diffuse or Mixed Type of Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma [Phase 3]
Phase 3 trial evaluating neoadjuvant cadonilimab plus perioperative oxaliplatin and S-1 for diffuse or mixed-type locally advanced gastric/G…
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: 89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors [Phase 2]
Telix's phase 2 trial of the CAIX-targeting PET tracer 89Zr-girentuximab in CAIX-positive solid tumors was terminated.
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers [Phase 2]
Phase 2 study evaluating adoptive transfer of tumor-infiltrating lymphocytes (TIL) for advanced solid cancers, with multiple site-specific i…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: A Beta-only IL-2 ImmunoTherapY Study [Phase 1, Phase 2]
Medicennа Therapeutics is evaluating a beta-only IL-2 immunotherapy (MDNA11) in Phase 1/2 across multiple advanced solid tumors; recruitment…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Efficacy and Safety of Minimally Invasive D2+PAND Gastrectomy for Gastric Cancer With PAN Metastasis After Conversion Immunochemotherapy [NA]
A clinical trial investigating a minimally invasive D2+PAND gastrectomy for gastric cancer with PAN metastasis after conversion immunochemot…
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: Berzosertib and Irinotecan in Treating Patients With Progressive, Metastatic, or Unresectable TP53 Mutant Gastric or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial evaluating the combination of berzosertib with irinotecan for TP53-mutant advanced gastric or gastroesophageal junction cancer…